
03 Apr Cirsium Biosciences
Daniel Gibbs, Ph.D., Founder and CEO
April 16 | 10:15am | Salone dei Cavalieri, Section 2
San Diego, CA
(Private)
Cirsium Biosciences is a San Diego based growth stage biotechnology start up company developing next generation biomanufacturing technologies using transient gene delivery in whole tobacco as a modular production platform for the fast, scalable and cost efective production of clinical grade (cGMP) viral vectors for gene therapies. Our industrial plant based production platform produces high quality AAV vectors with demonstrated enhancements in performance, including increased potency and reduced immunogenicity in vivo in clinically relevant large animal models. Our mission is to democratize access to gene therapies globally by addressing existing critical bottlenecks in cGMP viral vector production for genetic medicines.